| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.58 | 0.08 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |